aluates Reports

$ 0.0

Automative

Global Favipiravir Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-33V8810

BUY CHAPTERS

Global Favipiravir Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-33V8810

Report

August 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Cipla Ltd

Lupin Ltd

Sun Pharma

Hisun Pharm

Favipiravir Sales Market Size

The global Favipiravir market size was US$ 40.3 million in 2024 and is forecast to a readjusted size of US$ 7.3 million by 2031 with a CAGR of -22.0% during the forecast period 2025-2031.

Favipiravir Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Favipiravir market competitiveness, regional economic performance, and supply chain configurations.

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

The Favipiravir market has witnessed accelerated growth primarily due to the global urgency for effective antiviral therapies during outbreaks such as COVID-19. Its broad-spectrum activity against RNA viruses makes it a valuable candidate in pandemic preparedness plans. Several countries have approved Favipiravir for emergency or conditional use during viral outbreaks, boosting its visibility and adoption. Moreover, the drug's oral administration route offers ease of distribution and use, particularly in low-resource settings where intravenous treatments are less feasible. Continued investment in antiviral drug research, government stockpiling programs, and the rising incidence of emerging infectious diseases are expected to sustain demand for Favipiravir and similar oral antivirals in the foreseeable future.

Despite its potential, the Favipiravir market faces significant challenges. Clinical data regarding its efficacy for diseases beyond influenza, especially COVID-19, remains mixed, which has led to varied regulatory responses across different countries. Concerns over side effects such as teratogenicity limit its use among certain patient groups, particularly pregnant women. Additionally, the presence of more effective or better-studied antiviral drugs—like remdesivir, molnupiravir, and Paxlovid—creates intense competition in the antiviral space. Intellectual property issues and varying manufacturing standards across countries also affect the consistency of Favipiravir supply and global acceptance, complicating its market expansion.

In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market.

The global Favipiravir market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Favipiravir Sales Market Report

Report Metric	Details
Report Name	Favipiravir Sales Market
Forecasted market size in 2031	US$ 7.3 million
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Brand Drug Generic Drug
By Application: (Core Demand Driver vs Emerging Opportunity)	Influenza Viruses COVID-19 Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma, Hisun Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Favipiravir market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Generic Drug in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., COVID-19 in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Brand Drug dominance in Europe vs. Generic Drug demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Favipiravir Sales Market size in 2031?

Ans: The Favipiravir Sales Market size in 2031 will be US$ 7.3 million.

What is the Favipiravir Sales Market share by region?

Ans: India hold a key market revenue share of the Favipiravir market which account for 73%.

What is the Favipiravir Sales Market share by type?

Ans: Brand Drug accounted for a share of 16% in the global Favipiravir market.

Who are the main players in the Favipiravir Sales Market report?

Ans: The main players in the Favipiravir Sales Market are ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma, Hisun Pharm

What are the Application segmentation covered in the Favipiravir Sales Market report?

Ans: The Applications covered in the Favipiravir Sales Market report are Influenza Viruses, COVID-19, Others

What are the Type segmentation covered in the Favipiravir Sales Market report?

Ans: The Types covered in the Favipiravir Sales Market report are Brand Drug, Generic Drug

1 Market Overview

1.1 Favipiravir Product Scope

1.2 Favipiravir by Type

1.2.1 Global Favipiravir Sales by Type (2020 & 2024 & 2031)

1.2.2 Brand Drug

1.2.3 Generic Drug

1.3 Favipiravir by Application

1.3.1 Global Favipiravir Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Influenza Viruses

1.3.3 COVID-19

1.3.4 Others

1.4 Global Favipiravir Market Estimates and Forecasts (2020-2031)

1.4.1 Global Favipiravir Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Favipiravir Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Favipiravir Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Favipiravir Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Favipiravir Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Favipiravir Sales Market Share by Region (2020-2025)

2.2.2 Global Favipiravir Revenue Market Share by Region (2020-2025)

2.3 Global Favipiravir Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Favipiravir Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Favipiravir Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Favipiravir Market Size and Prospective (2020-2031)

2.4.2 Europe Favipiravir Market Size and Prospective (2020-2031)

2.4.3 China Favipiravir Market Size and Prospective (2020-2031)

2.4.4 Japan Favipiravir Market Size and Prospective (2020-2031)

2.4.5 India Favipiravir Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Favipiravir Historic Market Review by Type (2020-2025)

3.1.1 Global Favipiravir Sales by Type (2020-2025)

3.1.2 Global Favipiravir Revenue by Type (2020-2025)

3.1.3 Global Favipiravir Price by Type (2020-2025)

3.2 Global Favipiravir Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Favipiravir Sales Forecast by Type (2026-2031)

3.2.2 Global Favipiravir Revenue Forecast by Type (2026-2031)

3.2.3 Global Favipiravir Price Forecast by Type (2026-2031)

3.3 Different Types Favipiravir Representative Players

4 Global Market Size by Application

4.1 Global Favipiravir Historic Market Review by Application (2020-2025)

4.1.1 Global Favipiravir Sales by Application (2020-2025)

4.1.2 Global Favipiravir Revenue by Application (2020-2025)

4.1.3 Global Favipiravir Price by Application (2020-2025)

4.2 Global Favipiravir Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Favipiravir Sales Forecast by Application (2026-2031)

4.2.2 Global Favipiravir Revenue Forecast by Application (2026-2031)

4.2.3 Global Favipiravir Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Favipiravir Application

5 Competition Landscape by Players

5.1 Global Favipiravir Sales by Players (2020-2025)

5.2 Global Top Favipiravir Players by Revenue (2020-2025)

5.3 Global Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2024)

5.4 Global Favipiravir Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Favipiravir, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Favipiravir, Product Type & Application

5.7 Global Key Manufacturers of Favipiravir, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Favipiravir Sales by Company

6.1.1.1 North America Favipiravir Sales by Company (2020-2025)

6.1.1.2 North America Favipiravir Revenue by Company (2020-2025)

6.1.2 North America Favipiravir Sales Breakdown by Type (2020-2025)

6.1.3 North America Favipiravir Sales Breakdown by Application (2020-2025)

6.1.4 North America Favipiravir Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Favipiravir Sales by Company

6.2.1.1 Europe Favipiravir Sales by Company (2020-2025)

6.2.1.2 Europe Favipiravir Revenue by Company (2020-2025)

6.2.2 Europe Favipiravir Sales Breakdown by Type (2020-2025)

6.2.3 Europe Favipiravir Sales Breakdown by Application (2020-2025)

6.2.4 Europe Favipiravir Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Favipiravir Sales by Company

6.3.1.1 China Favipiravir Sales by Company (2020-2025)

6.3.1.2 China Favipiravir Revenue by Company (2020-2025)

6.3.2 China Favipiravir Sales Breakdown by Type (2020-2025)

6.3.3 China Favipiravir Sales Breakdown by Application (2020-2025)

6.3.4 China Favipiravir Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Favipiravir Sales by Company

6.4.1.1 Japan Favipiravir Sales by Company (2020-2025)

6.4.1.2 Japan Favipiravir Revenue by Company (2020-2025)

6.4.2 Japan Favipiravir Sales Breakdown by Type (2020-2025)

6.4.3 Japan Favipiravir Sales Breakdown by Application (2020-2025)

6.4.4 Japan Favipiravir Major Customer

6.4.5 Japan Market Trend and Opportunities

6.5 India Market: Players, Segments, Downstream and Major Customers

6.5.1 India Favipiravir Sales by Company

6.5.1.1 India Favipiravir Sales by Company (2020-2025)

6.5.1.2 India Favipiravir Revenue by Company (2020-2025)

6.5.2 India Favipiravir Sales Breakdown by Type (2020-2025)

6.5.3 India Favipiravir Sales Breakdown by Application (2020-2025)

6.5.4 India Favipiravir Major Customer

6.5.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 ChemRar Group

7.1.1 ChemRar Group Company Information

7.1.2 ChemRar Group Business Overview

7.1.3 ChemRar Group Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.1.4 ChemRar Group Favipiravir Products Offered

7.1.5 ChemRar Group Recent Development

7.2 Glenmark

7.2.1 Glenmark Company Information

7.2.2 Glenmark Business Overview

7.2.3 Glenmark Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Glenmark Favipiravir Products Offered

7.2.5 Glenmark Recent Development

7.3 Fujifilm

7.3.1 Fujifilm Company Information

7.3.2 Fujifilm Business Overview

7.3.3 Fujifilm Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Fujifilm Favipiravir Products Offered

7.3.5 Fujifilm Recent Development

7.4 Dr. Reddy

7.4.1 Dr. Reddy Company Information

7.4.2 Dr. Reddy Business Overview

7.4.3 Dr. Reddy Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Dr. Reddy Favipiravir Products Offered

7.4.5 Dr. Reddy Recent Development

7.5 R-Pharma

7.5.1 R-Pharma Company Information

7.5.2 R-Pharma Business Overview

7.5.3 R-Pharma Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.5.4 R-Pharma Favipiravir Products Offered

7.5.5 R-Pharma Recent Development

7.6 Cipla

7.6.1 Cipla Company Information

7.6.2 Cipla Business Overview

7.6.3 Cipla Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Cipla Favipiravir Products Offered

7.6.5 Cipla Recent Development

7.7 Lupin

7.7.1 Lupin Company Information

7.7.2 Lupin Business Overview

7.7.3 Lupin Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Lupin Favipiravir Products Offered

7.7.5 Lupin Recent Development

7.8 Sun Pharma

7.8.1 Sun Pharma Company Information

7.8.2 Sun Pharma Business Overview

7.8.3 Sun Pharma Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Sun Pharma Favipiravir Products Offered

7.8.5 Sun Pharma Recent Development

7.9 Hisun Pharm

7.9.1 Hisun Pharm Company Information

7.9.2 Hisun Pharm Business Overview

7.9.3 Hisun Pharm Favipiravir Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Hisun Pharm Favipiravir Products Offered

7.9.5 Hisun Pharm Recent Development

8 Favipiravir Manufacturing Cost Analysis

8.1 Favipiravir Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Favipiravir

8.4 Favipiravir Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Favipiravir Distributors List

9.3 Favipiravir Customers

10 Favipiravir Market Dynamics

10.1 Favipiravir Industry Trends

10.2 Favipiravir Market Drivers

10.3 Favipiravir Market Challenges

10.4 Favipiravir Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Cipla Ltd

Lupin Ltd

Sun Pharma

Hisun Pharm

List of Tables

Table 1. Global Favipiravir Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Favipiravir Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Favipiravir Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Favipiravir Sales (K Units) by Region (2020-2025)

Table 5. Global Favipiravir Sales Market Share by Region (2020-2025)

Table 6. Global Favipiravir Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Favipiravir Revenue Share by Region (2020-2025)

Table 8. Global Favipiravir Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Favipiravir Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Favipiravir Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Favipiravir Revenue Share Forecast by Region (2026-2031)

Table 12. Global Favipiravir Sales by Type (K Units) & (2020-2025)

Table 13. Global Favipiravir Sales Share by Type (2020-2025)

Table 14. Global Favipiravir Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Favipiravir Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Favipiravir Sales by Type (K Units) & (2026-2031)

Table 17. Global Favipiravir Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Favipiravir Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Favipiravir Sales by Application (K Units) & (2020-2025)

Table 21. Global Favipiravir Sales Share by Application (2020-2025)

Table 22. Global Favipiravir Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Favipiravir Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Favipiravir Sales by Application (K Units) & (2026-2031)

Table 25. Global Favipiravir Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Favipiravir Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Favipiravir Application

Table 28. Global Favipiravir Sales by Company (K Units) & (2020-2025)

Table 29. Global Favipiravir Sales Share by Company (2020-2025)

Table 30. Global Favipiravir Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Favipiravir Revenue Share by Company (2020-2025)

Table 32. Global Favipiravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2024)

Table 33. Global Market Favipiravir Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Favipiravir, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Favipiravir, Product Type & Application

Table 36. Global Key Manufacturers of Favipiravir, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Favipiravir Sales by Company (2020-2025) & (K Units)

Table 39. North America Favipiravir Sales Market Share by Company (2020-2025)

Table 40. North America Favipiravir Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Favipiravir Revenue Market Share by Company (2020-2025)

Table 42. North America Favipiravir Sales by Type (2020-2025) & (K Units)

Table 43. North America Favipiravir Sales Market Share by Type (2020-2025)

Table 44. North America Favipiravir Sales by Application (2020-2025) & (K Units)

Table 45. North America Favipiravir Sales Market Share by Application (2020-2025)

Table 46. Europe Favipiravir Sales by Company (2020-2025) & (K Units)

Table 47. Europe Favipiravir Sales Market Share by Company (2020-2025)

Table 48. Europe Favipiravir Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Favipiravir Revenue Market Share by Company (2020-2025)

Table 50. Europe Favipiravir Sales by Type (2020-2025) & (K Units)

Table 51. Europe Favipiravir Sales Market Share by Type (2020-2025)

Table 52. Europe Favipiravir Sales by Application (2020-2025) & (K Units)

Table 53. Europe Favipiravir Sales Market Share by Application (2020-2025)

Table 54. China Favipiravir Sales by Company (2020-2025) & (K Units)

Table 55. China Favipiravir Sales Market Share by Company (2020-2025)

Table 56. China Favipiravir Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Favipiravir Revenue Market Share by Company (2020-2025)

Table 58. China Favipiravir Sales by Type (2020-2025) & (K Units)

Table 59. China Favipiravir Sales Market Share by Type (2020-2025)

Table 60. China Favipiravir Sales by Application (2020-2025) & (K Units)

Table 61. China Favipiravir Sales Market Share by Application (2020-2025)

Table 62. Japan Favipiravir Sales by Company (2020-2025) & (K Units)

Table 63. Japan Favipiravir Sales Market Share by Company (2020-2025)

Table 64. Japan Favipiravir Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Favipiravir Revenue Market Share by Company (2020-2025)

Table 66. Japan Favipiravir Sales by Type (2020-2025) & (K Units)

Table 67. Japan Favipiravir Sales Market Share by Type (2020-2025)

Table 68. Japan Favipiravir Sales by Application (2020-2025) & (K Units)

Table 69. Japan Favipiravir Sales Market Share by Application (2020-2025)

Table 70. India Favipiravir Sales by Company (2020-2025) & (K Units)

Table 71. India Favipiravir Sales Market Share by Company (2020-2025)

Table 72. India Favipiravir Revenue by Company (2020-2025) & (US$ Million)

Table 73. India Favipiravir Revenue Market Share by Company (2020-2025)

Table 74. India Favipiravir Sales by Type (2020-2025) & (K Units)

Table 75. India Favipiravir Sales Market Share by Type (2020-2025)

Table 76. India Favipiravir Sales by Application (2020-2025) & (K Units)

Table 77. India Favipiravir Sales Market Share by Application (2020-2025)

Table 78. ChemRar Group Company Information

Table 79. ChemRar Group Description and Business Overview

Table 80. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. ChemRar Group Favipiravir Product

Table 82. ChemRar Group Recent Development

Table 83. Glenmark Company Information

Table 84. Glenmark Description and Business Overview

Table 85. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 86. Glenmark Favipiravir Product

Table 87. Glenmark Recent Development

Table 88. Fujifilm Company Information

Table 89. Fujifilm Description and Business Overview

Table 90. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 91. Fujifilm Favipiravir Product

Table 92. Fujifilm Recent Development

Table 93. Dr. Reddy Company Information

Table 94. Dr. Reddy Description and Business Overview

Table 95. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. Dr. Reddy Favipiravir Product

Table 97. Dr. Reddy Recent Development

Table 98. R-Pharma Company Information

Table 99. R-Pharma Description and Business Overview

Table 100. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 101. R-Pharma Favipiravir Product

Table 102. R-Pharma Recent Development

Table 103. Cipla Company Information

Table 104. Cipla Description and Business Overview

Table 105. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 106. Cipla Favipiravir Product

Table 107. Cipla Recent Development

Table 108. Lupin Company Information

Table 109. Lupin Description and Business Overview

Table 110. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 111. Lupin Favipiravir Product

Table 112. Lupin Recent Development

Table 113. Sun Pharma Company Information

Table 114. Sun Pharma Description and Business Overview

Table 115. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 116. Sun Pharma Favipiravir Product

Table 117. Sun Pharma Recent Development

Table 118. Hisun Pharm Company Information

Table 119. Hisun Pharm Description and Business Overview

Table 120. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 121. Hisun Pharm Favipiravir Product

Table 122. Hisun Pharm Recent Development

Table 123. Production Base and Market Concentration Rate of Raw Material

Table 124. Key Suppliers of Raw Materials

Table 125. Favipiravir Distributors List

Table 126. Favipiravir Customers List

Table 127. Favipiravir Market Trends

Table 128. Favipiravir Market Drivers

Table 129. Favipiravir Market Challenges

Table 130. Favipiravir Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Favipiravir Product Picture

Figure 2. Global Favipiravir Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Favipiravir Sales Market Share by Type in 2024 & 2031

Figure 4. Brand Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Favipiravir Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Favipiravir Sales Market Share by Application in 2024 & 2031

Figure 8. Influenza Viruses Examples

Figure 9. COVID-19 Examples

Figure 10. Others Examples

Figure 11. Global Favipiravir Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Favipiravir Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 14. Global Favipiravir Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 15. Favipiravir Report Years Considered

Figure 16. Global Market Favipiravir Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Favipiravir Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Favipiravir Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 20. Europe Favipiravir Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 22. China Favipiravir Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 24. Japan Favipiravir Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 26. India Favipiravir Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. India Favipiravir Sales (K Units) Growth Rate (2020-2031)

Figure 28. Global Favipiravir Revenue Share by Type (2020-2025)

Figure 29. Global Favipiravir Sales Share by Type (2026-2031)

Figure 30. Global Favipiravir Revenue Share by Type (2026-2031)

Figure 31. Global Favipiravir Revenue Share by Application (2020-2025)

Figure 32. Global Favipiravir Revenue Growth Rate by Application in 2020 & 2024

Figure 33. Global Favipiravir Sales Share by Application (2026-2031)

Figure 34. Global Favipiravir Revenue Share by Application (2026-2031)

Figure 35. Global Favipiravir Sales Share by Company (2024)

Figure 36. Global Favipiravir Revenue Share by Company (2024)

Figure 37. Global 5 Largest Favipiravir Players Market Share by Revenue in Favipiravir: 2020 & 2024

Figure 38. Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Manufacturing Cost Structure of Favipiravir

Figure 40. Manufacturing Process Analysis of Favipiravir

Figure 41. Favipiravir Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Efavirenz API Market Research Report 2025

Zanamivir Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Valacyclovir API Market Research Report 2025

Global Valganciclovir API Market Research Report 2025

Influenza Antiviral Drugs Market

Human Papillomaviru Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Grade Avanafil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tamiflu Oseltamivir Phosphate Market Insights Forecast to 2030

Oseltamivir Phosphate Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Efavirenz Market Insights Forecast to 2030

Global Respiratory Antiviral Treatment Market Research Report 2024

Global Oseltamivir Market Insights Forecast to 2030

Global Antiviral Drugs for Influenza Market Research Report 2025

Fipronil API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oseltamivir Phosphate API Market Research Report 2025

Global Nevirapine API Market Research Report 2025

Global Emtricitabine Rilpivirine Tenofovir Alafenamide Market Research Report 2024

Viral Pneumonia Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions